See the latest news highlighting their prestigious awards at SNMMI 2022 Congratulations to investigators for exceptional FAPI research SNMMI Image of the year 2022
JNM paper of the year 2021
We are committed to the future of molecularly targeted therapeutics and companion diagnostics
Center of Excellence
Take a video tour
We are pleased to offer our academic community the use of FAPI as a diagnostic or companion diagnostic tool.
Be part of the FAPI Community
Find out more
With over 50 years of passion and dedication for the future of PET, we have taken bold steps to advance the development of next generation radiopharmaceuticals.
To improve patient outcomes by developing and delivering molecular diagnostics and therapeutics (theranostics). With our robust radiopharmaceutical production and distribution network, mature contract manufacturing services, and now, high value radiopharmaceutical intellectual property, we are poised to deliver on the promise of radiopharmaceuticals.